developed and recent well-designed, well-powered, doubleblinded, placebo-controlled studies demonstrated efficacy and safety of tablet formulation [17] [18] [19] [20] .
Some of those studies improved our understanding of the underlying immunological mechanisms in addition to the proven safety and efficacy. Recent studies demonstrated that SLIT exerts its immune-suppressive effect through the induction of Treg cytokines such as IL-10 and TGF-beta [21, 22] . This effect starts on the uptake of allergen by oral mucosal Langerhans cells through high-affinity IgE receptors [6] . More recent studies demonstrated increase in expression of Foxp3+ cells in the sublingual mucosa, which was accompanied by the systemic immunologic response during SLIT [23] .
Hereby in this issue, data on clinical implications, efficacy, compliance, monitorization of delivery, and immunological mechanisms of allergen SIT delivered by the mucosalmainly sublingual route will be presented.
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